Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Special Investigation for VIZIMPRO Tablets (Secondary Data Collection Study; Safety and Efficacy of VIZIMPRO Under Japanese Medical Practice)
A completed special investigation collecting safety and efficacy data for VIZIMPRO (dacomitinib) in EGFR mutation-positive non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial update covers Nano-SMART, a nanoparticle therapy with MR-guided SBRT being studied in centrally located lung tumors and …
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene Mutations [Phase 1]
A Phase 1 trial is evaluating the combination of pembrolizumab and trametinib for patients with stage IV non-small cell lung cancer, includi…
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China [Phase 1]
The Phase 1 study of JAB-3312 in adults with advanced solid tumors in China has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: TGRX-326 Pharmacokinetic Food Effect Bioavailability Study [Phase 1]
Phase 1 pharmacokinetic study evaluating the impact of food on the bioavailability of a drug in development for non-small cell lung cancer; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer
A completed clinical trial evaluating whether circulating tumor DNA can predict outcomes in patients with stage IV head and neck cancer or s…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Continued Access to RXDX-105 [Phase 1]
This clinical trial update concerns continued access to RXDX-105 in a Phase 1 study for non-small cell lung cancer and ovarian cancer, inclu…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase (ALK)-Positive, Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase I/II study evaluating the combination of alectinib and bevacizumab in ALK-positive non-small cell lung cancer was terminated, with r…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating APR-246 in combination with pembrolizumab in solid tumors has completed enrollment with results posted…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 study evaluating NC318 alone or in combination with pembrolizumab in adults with advanced non-small cell lung cancer is active but…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867) [Phase 3]
A Phase 3 trial evaluating stereotactic body radiotherapy with or without pembrolizumab in adults with unresected stage I–II non-small cell …
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Pembrolizumab With Standard Cytotoxic Chemotherapy in Treatment Naive NSCLC Patients With Asymptomatic Brain Metastases [Phase 2]
Phase 2 study evaluating pembrolizumab in combination with standard cytotoxic chemotherapy as first-line treatment for treatment-naive non-s…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab [Phase 1]
This is a Phase 1/Ib study of NIZ985 alone and in combination with spartalizumab, sponsored by Novartis, which has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-05-04Clinical Trial Update: Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Phase 1/2 study evaluating pembrolizumab in combination with vorinostat for patients with stage IV non-small cell lung cancer, with results …
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer [Phase 1]
A Phase 1 study evaluated the combination of pemetrexed (Alimta) and carboplatin with radiation therapy in patients with inoperable non-smal…
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer [Phase 1]
This Phase 1 study evaluates VIC-1911 as a monotherapy and in combination with Sotorasib for KRAS G12C-mutant non-small cell lung cancer. Th…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients [NA]
This clinical trial update reports on the prognostic value of tumor hypoxia in non-small cell lung cancer as measured by 18F-FMISO breath-ho…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum
Clinical trial update indicating the CHAIMELEON AI solution evaluation for prostate, breast, colon, rectal, and non-small cell lung cancers …
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Induction Chemo-Nivo in Unresectable Stage III NSCLC [Phase 2]
Phase 2 trial evaluating induction chemotherapy with nivolumab for unresectable stage III non-small cell lung cancer has been terminated. Re…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 [Phase 2]
Phase 2 trial of ponsegromab in cancer patients with cachexia and elevated GDF-15 completed; results posted.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial update for the MIDRIXNEO-LUNG Dendritic Cell Vaccine in non-small cell lung cancer; the study at University Hospital …
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung Cancer [NA]
A completed clinical trial from Thomas Jefferson University evaluated how integrating genetic information and shared decision making affects…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma [Phase 2]
A Phase 2 study completed in Asian participants evaluated Erdafitinib, a pan-FGFR tyrosine kinase inhibitor, for efficacy in advanced non-sm…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: First-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment With EGFR TKI [Phase 1, Phase 2]
First-in-human Phase 1/2 trial of BBT-207 in EGFR-mutant advanced non-small cell lung cancer after prior EGFR TKI therapy is underway.
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC [Phase 2]
A Phase 2 clinical trial of JS207 combined with chemotherapy for stage II-III non-small cell lung cancer is currently not recruiting.